Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients with Advanced Solid Tumors”

3,877 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,877 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Early research (Phase 1)Ended earlyNCT01705106
What this trial is testing

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Chicago 21
Testing effectiveness (Phase 2)Looking for participantsNCT06003621
What this trial is testing

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Who this might be right for
Solid Tumor, Adult
Omico 96
Early research (Phase 1)Ended earlyNCT04835714
What this trial is testing

Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Who this might be right for
Solid Tumors, KRAS Mutation
Boehringer Ingelheim 8
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Looking for participantsNCT05857332
What this trial is testing

SG1906 for CLDN18.2-Positive Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd. 60
Early research (Phase 1)Study completedNCT01919398
What this trial is testing

LY2940680 in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 19
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Testing effectiveness (Phase 2)Looking for participantsNCT05970016
What this trial is testing

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Who this might be right for
Patients with Advanced Solid Tumors
Beijing Tide Pharmaceutical Co., Ltd 56
Early research (Phase 1)Study completedNCT03133247
What this trial is testing

A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients

Who this might be right for
Advanced Solid Tumors
Atridia Pty Ltd. 37
Early research (Phase 1)Looking for participantsNCT06211647
What this trial is testing

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ruimin Wang 20
Early research (Phase 1)Study completedNCT00165802
What this trial is testing

A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors

Who this might be right for
Cancer, Malignant Tumors
Eisai Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Early research (Phase 1)Study completedNCT03077607
What this trial is testing

Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 36
Early research (Phase 1)Looking for participantsNCT04740398
What this trial is testing

CBP-1008 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Coherent Biopharma (Suzhou) Co., Ltd. 143
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852
What this trial is testing

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT04975958
What this trial is testing

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Adlai Nortye Biopharma Co., Ltd. 47
Early research (Phase 1)Study completedNCT00003207
What this trial is testing

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Who this might be right for
SarcomaUnspecified Adult Solid Tumor, Protocol Specific
Washington University School of Medicine 14
Early research (Phase 1)Study completedNCT04094506
What this trial is testing

Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Astellas Pharma Inc 9
Early research (Phase 1)Study completedNCT02004106
What this trial is testing

Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 110
Load More Results